As of 2026-09-25, the EV/EBITDA ratio of AnaptysBio Inc (ANAB) is -40.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AnaptysBio's latest enterprise value is 1,546.11 mil USD. AnaptysBio's TTM EBITDA according to its financial statements is -37.82 mil USD. Dividing these 2 quantities gives us the above AnaptysBio EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 16.0x | 13.2x |
| Forward P/E multiples | 12.5x - 17.8x | 16.7x |
| Fair Price | (16.43) - (20.95) | (19.58) |
| Upside | -131.8% - -140.5% | -137.9% |
| Date | EV/EBITDA |
| 2026-09-24 | -40.88 |
| 2026-09-23 | -40.15 |
| 2026-09-22 | -42.62 |
| 2026-09-21 | -43.40 |
| 2026-09-18 | -43.62 |
| 2026-09-17 | -43.51 |
| 2026-09-16 | -42.92 |
| 2026-09-15 | -43.21 |
| 2026-09-14 | -42.76 |
| 2026-09-11 | -42.58 |
| 2026-09-10 | -43.59 |
| 2026-09-09 | -44.01 |
| 2026-09-08 | -44.71 |
| 2026-09-04 | -44.87 |
| 2026-09-03 | -45.39 |
| 2026-09-02 | -44.12 |
| 2026-09-01 | -43.68 |
| 2026-08-31 | -45.05 |
| 2026-08-28 | -44.46 |
| 2026-08-27 | -45.25 |
| 2026-08-26 | -45.81 |
| 2026-08-25 | -46.10 |
| 2026-08-24 | -46.15 |
| 2026-08-21 | -45.61 |
| 2026-08-20 | -44.78 |
| 2026-08-19 | -46.80 |
| 2026-08-18 | -46.58 |
| 2026-08-17 | -47.13 |
| 2026-08-14 | -46.18 |
| 2026-08-13 | -44.26 |
| 2026-08-12 | -45.01 |
| 2026-08-11 | -45.71 |
| 2026-08-10 | -43.83 |
| 2026-08-07 | -44.72 |
| 2026-08-06 | -43.28 |
| 2026-08-05 | -43.45 |
| 2026-08-04 | -43.56 |
| 2026-08-03 | -42.41 |
| 2026-07-31 | -42.18 |
| 2026-07-30 | -43.49 |
| 2026-07-29 | -41.22 |
| 2026-07-28 | -41.20 |
| 2026-07-27 | -42.37 |
| 2026-07-24 | -42.80 |
| 2026-07-23 | -43.39 |
| 2026-07-22 | -41.59 |
| 2026-07-21 | -42.49 |
| 2026-07-20 | -39.77 |
| 2026-07-17 | -45.81 |
| 2026-07-16 | -42.80 |